Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Infections × Cefazolin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Wound Infection 2 Surgical Wound Infection 1 Prostatic Neoplasms 1 Laryngeal Neoplasms 1 Infections 1 Clinical Stage I Cutaneous Melanoma AJCC v8 1 Carcinoma, Hepatocellular 1

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7 Ciprofloxacin 7 Vancomycin 4 Voriconazole 3 Fluconazole 3 Antibiotic Prophylaxis 3 Amoxicillin-Potassium Clavulanate Combination 3 plerixafor 2 gamma-Globulins 2 Therapeutics 2 Ribavirin 2 Polymerase Chain Reaction 2 Piperacillin, Tazobactam Drug Combination 2 Moxifloxacin 2 Levofloxacin 2 Lenalidomide 2 Immunoglobulins, Intravenous 2 Granulocyte Colony-Stimulating Factor 2 Fosfomycin 2 Filgrastim 2 Daptomycin 2 Cefepime 2 Caspofungin 2 ziprasidone 1 tocilizumab 1 threonic acid 1 telavancin 1 telaprevir 1 talquetamab 1 soybean oil, phospholipid emulsion 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00867295 2010-06-02

TIVAD

Istanbul University

Phase 3 Completed

Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡